Get notified when NUS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsNu Skin stockholders approve equity plan adding 2.85M shares, extending term to 2036
Filed May 29, 2026 · Period ending May 28, 2026 · ~1 min read
Key Changes
-
medium
Stockholders approved amended equity incentive plan that increases share authorization by 2.85 million shares for employee and executive compensation awards, potentially diluting existing shareholders.
Item 5.07 verify on EDGAR → -
low
Plan termination date extended to May 28, 2036, giving company a 10-year window to grant stock options, restricted stock, and other equity-based compensation under this framework.
Item 5.07 verify on EDGAR → -
low
All annual meeting proposals passed including election of nine directors, advisory approval of executive compensation, and ratification of PricewaterhouseCoopers as 2026 auditor.
Item 5.07 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (NKE 10-K) is open in full — no account needed.
Partner
Trade NUS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify